Tras llevar a cabo la evaluacin y revisin de toda la evidencia disponible, EMA acaba de confirmar que, efectivamente, la semaglutida, el principio activo de los famosos medicamentos para adelgazar y para la diabetes mellitus tipo 2 Wegovy, Ozempic y Rybelsus, puede producir NAION , si bien, esto ocurre en muy pocas ocasiones: hasta en uno de cada 10.000 personas, por lo que es un efecto adverso muy raro
This initially raised serious concerns
Nancy Knight Chief Science and Programs Officer The Task Force for Global Health Ben Lopman Professor of Epidemiology Director Emory Center for Infectious Disease Modeling & Analytics and Training Hub Rollins School of Public Health Emory University Wilbur Lam Professor of Pediatrics and Biomedical Engineering
Are cost-sensitive and don't have insurance coverage for GLP-1 medications: If your insurance doesn't cover weight loss medications (or if you don't have insurance), Elevate Health's $114-$263/month pricing with payment plan options may be more accessible than $1,000+ monthly costs for brand-name medications
Key variants (FTO rs9939609) may indicate whether you tend toward greater insulin sensitivity gains or slower weight loss plateausdata your provider can use alongside thyroid biomarkers to guide treatment timing and intensity